Adial Pharmaceuticals, Inc. Assets Sold under Agreements to Repurchase, Market Value
Adial Pharmaceuticals, Inc. (ADIL) had Assets Sold under Agreements to Repurchase, Market Value of $4.28 million as of 2024-06-30, per its 10-Q filed 2024-08-13.
Discontinued › Notes › Financial Services
us-gaap:AssetsSoldUnderAgreementsToRepurchaseMarketValue · last filed 2024-08-13
- 2024-06-30: Assets Sold under Agreements to Repurchase, Market Value $4.28M.
| Period end | Assets Sold under Agreements to Repurchase, Market Value |
|---|---|
| 2024-06-30 | $4.28M 10-Q · filed 2024-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |